Cilostazol - CISMeF

Preferred Label : Cilostazol;

MeSH definition : A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke.;

MeSH synonym : 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone;

MeSH hyponym : OPC-13013;

MeSH CAS label : 2(1H)-Quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-;

MeSH Related Number : 73963-72-1 (Cilostazol);

Wikipedia link : https://en.wikipedia.org/wiki/Cilostazol;

UNII : N7Z035406B;

Details

Origin ID

D000077407;

UMLS CUI

C0055729;

ATC code(s)
- cilostazol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Pharmacological action(s)
- bronchodilator agents [MeSH Descriptor]
- fibrinolytic agents [MeSH Descriptor]
- neuroprotective agents [MeSH Descriptor]
- peripheral nervous system agents [MeSH Descriptor]
- phosphodiesterase 3 inhibitors [MeSH Descriptor]
- platelet aggregation inhibitors [MeSH Descriptor]
- vasodilator agents [MeSH Descriptor]
Record concept(s)
- OPC 13013 [MeSH concept]
- cilostazol [MeSH concept]
- pletal [MeSH concept]
Related MeSH Supplementary Concept(s)
- 4'-trans-hydroxy cilostazol [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cilostazol [NCIt concept]
- Cilostazol (substance) [SNOMED CT concept]
- Product containing cilostazol (medicinal product) [SNOMED CT concept]
- cilostazol [ATC Code]
Validated automatic mappings to BTNT
- cilostazol [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients